Conagra Brands
CAG
13.25
-0.20
-1.49%
Conagra Brands
US · CAG
#1878 by market cap
Listed 1970
13.25
-0.20
-1.49%
Live - 5344 symbols - heartbeat 535s ago
· 2026-10-08 08:15
Pre-market
13.33
+0.60%
After-hours
13.35
+0.75%
Overnight
13.26
+0.08%
- Market cap
- 6.33B
- P/E (TTM)i
- -3.33
- P/Bi
- 0.99
- EPSi
- -4.00
- Div yieldi
- 9.25%
- 52W posi
- 12%
Reader sentiment
Are you bullish or bearish on CAG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.56, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.85% YoY
Margins
- Gross margin
- 23.92%
- Operating margin
- 11.16%
- Net margin
- -16.99%
Key ratios & quality
- Enterprise valuei
- 13.38B
- Altman Z-Scorei
- 1.56
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.54B | 11.05B | 11.18B | 11.54B | 12.28B | 12.05B | 11.61B | 11.28B |
| Gross profit | 2.65B | 3.07B | 3.18B | 2.84B | 3.26B | 3.33B | 3.00B | 2.70B |
| Selling & admin expenses | 1.47B | 1.62B | 1.40B | 1.49B | 1.43B | 1.49B | 1.54B | 1.44B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.18B | 1.45B | 1.78B | 1.35B | 1.83B | 1.85B | 1.47B | 1.26B |
| Pretax profit | 823.30M | 969.90M | 1.41B | 1.18B | 901.90M | 610.20M | 1.16B | -1.82B |
| Tax | 218.80M | 201.30M | 193.80M | 290.50M | 218.70M | 262.50M | 3.70M | 91.80M |
| Net profit | 678.40M | 841.80M | 1.30B | 888.20M | 683.20M | 347.70M | 1.15B | -1.92B |
| Basic EPS | 2 | 2 | 3 | 2 | 1 | 1 | 2 | -4 |
| Diluted EPS | 1.52 | 1.72 | 2.66 | 1.84 | 1.42 | 0.72 | 2.40 | -4.00 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 2.78B | 2.63B | 2.98B | 2.79B | 2.88B | 2.60B |
| Gross profit | 707.20M | 640.60M | 696.00M | 657.70M | 704.10M | 618.70M |
| Selling & admin expenses | 333.00M | 335.60M | 325.10M | 377.60M | 401.10M | 350.30M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 374.20M | 305.00M | 370.90M | 280.10M | 303.00M | 268.40M |
| Pretax profit | 293.20M | 289.10M | -655.30M | 229.60M | -1.69B | 232.90M |
| Tax | 37.20M | 124.60M | 8.30M | 29.80M | -70.90M | 58.60M |
| Net profit | 256.00M | 164.50M | -663.60M | 199.80M | -1.62B | 174.30M |
| Basic EPS | 1 | 0 | -1 | 0 | -3 | 0 |
| Diluted EPS | 0.53 | 0.34 | -1.39 | 0.42 | -3.37 | 0.36 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.73B | 2.89B | 2.70B | 3.03B | 3.39B | 3.15B | 3.07B | 2.88B |
| Cash & ST investments | 236.60M | 553.30M | 79.20M | 83.30M | 93.30M | 77.70M | 68.00M | 218.00M |
| Inventory | 1.55B | 1.36B | 1.71B | 1.97B | 2.21B | 1.98B | 2.05B | 1.91B |
| Total assets | 22.21B | 22.30B | 22.20B | 22.44B | 22.05B | 20.86B | 20.93B | 17.27B |
| Total current liabilities | 2.14B | 3.29B | 3.31B | 3.52B | 4.44B | 3.24B | 4.32B | 3.19B |
| Short-term debt | 21.60M | 846.60M | 730.50M | 891.60M | 2.15B | 948.70M | 1.83B | 812.40M |
| Long-term debt | 10.66B | 8.90B | 8.28B | 8.09B | 7.08B | 7.49B | 6.23B | 6.46B |
| Total liabilities | 14,750,100,000.00 | 14,353,300,000.00 | 13,564,200,000.00 | 13,572,900,000.00 | 13,245,300,000.00 | 12,351,000,000.00 | 12,001,200,000.00 | 10,916,800,000.00 |
| Total equity | 7.46B | 7.95B | 8.63B | 8.86B | 8.81B | 8.51B | 8.93B | 6.36B |
| Retained earnings | 5.05B | 5.47B | 6.26B | 6.55B | 6.60B | 6.28B | 6.76B | 4.17B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 3.07B | 3.84B | 3.23B | 2.89B | 2.88B | 3.36B |
| Cash & ST investments | 68.00M | 698.10M | 46.60M | 55.10M | 218.00M | 371.60M |
| Inventory | 2.05B | 2.26B | 2.20B | 1.94B | 1.91B | 2.15B |
| Total assets | 20.93B | 21.17B | 19.54B | 19.21B | 17.27B | 17.70B |
| Total current liabilities | 4.32B | 3.63B | 3.62B | 3.21B | 3.19B | 3.07B |
| Short-term debt | 1.83B | 1.06B | 1.16B | 875.30M | 812.40M | 820.00M |
| Long-term debt | 6.23B | 7.22B | 6.46B | 6.46B | 6.46B | 6.94B |
| Total liabilities | 12,001,200,000.00 | 12,257,000,000.00 | 11,449,500,000.00 | 11,048,200,000.00 | 10,916,800,000.00 | 11,296,600,000.00 |
| Total equity | 8.93B | 8.92B | 8.09B | 8.16B | 6.36B | 6.40B |
| Retained earnings | 6.76B | 6.76B | 5.92B | 5.96B | 4.17B | 4.26B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.13B | 1.84B | 1.47B | 1.18B | 995.40M | 2.02B | 1.69B | 1.40B |
| Depreciation & amortization | 333.00M | 388.90M | 387.70M | 375.40M | 369.90M | 400.90M | 390.20M | 396.00M |
| Free cash flow | 772.40M | 1.47B | 961.70M | 712.90M | 633.20M | 1.63B | 1.30B | 978.70M |
| Dividends paid | -356.20M | -413.60M | -474.60M | -581.80M | -623.80M | -659.30M | -669.20M | -669.70M |
| Stock buybacks / issuance | 555.70M | 0 | -298.10M | -50.00M | -150.00M | 0 | -64.00M | -15.30M |
| Ending cash balance | 237.60M | 554.30M | 80.20M | 82.20M | 93.30M | 77.70M | 68.00M | 218.00M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 345.70M | 120.60M | 210.60M | 564.40M | 506.50M | -4.20M |
| Depreciation & amortization | 95.30M | 95.30M | 97.00M | 101.40M | 102.30M | 97.90M |
| Free cash flow | 260.60M | -26.20M | 138.80M | 468.80M | 397.30M | -127.90M |
| Dividends paid | -167.00M | -167.10M | -167.70M | -167.40M | -167.50M | -167.50M |
| Stock buybacks / issuance | 0 | -15.00M | -300.00K | 0 | 0 | -44.00M |
| Ending cash balance | 68.00M | 698.10M | 46.60M | 55.10M | 218.00M | 371.60M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.26 | 11.01 | 15.81 | 10.24 | 7.80 | 4.04 | 13.27 | -25.06 |
| ROA %i | 4.16 | 3.77 | 5.84 | 3.98 | 3.07 | 1.62 | 5.51 | -10.03 |
| ROIC %i | 7.64 | 6.88 | 9.36 | 6.50 | 5.33 | 3.79 | 9.21 | -11.01 |
| 5-year avg ROE %i | 5.64 | 8.88 | 15.35 | 14.08 | 11.43 | 9.78 | 10.23 | 2.06 |
| EBIT margin %i | 12.81 | 13.21 | 16.38 | 12.27 | 8.99 | 8.68 | 13.57 | -12.71 |
| FCF / sales %i | 8.10 | 13.33 | 8.60 | 6.18 | 5.16 | 13.51 | 11.22 | 8.68 |
| Current ratioi | 1.28 | 0.88 | 0.82 | 0.86 | 0.76 | 0.97 | 0.71 | 0.90 |
| Quick ratioi | 0.49 | 0.43 | 0.26 | 0.27 | 0.24 | 0.29 | 0.19 | 0.27 |
| Debt / assetsi | 48.07 | 44.63 | 41.41 | 40.91 | 42.71 | 40.46 | 38.54 | 42.08 |
| LT debt / equityi | 144.30 | 115.63 | 98.93 | 94.31 | 83.18 | 88.77 | 69.79 | 101.55 |
| Interest coveragei | 3.07 | 2.98 | 4.34 | 3.71 | 2.67 | 2.40 | 3.76 | -3.68 |
| Revenue CAGR (3Y) %i | 3.26 | 12.20 | 12.11 | 6.54 | 3.56 | 2.52 | 0.22 | -2.78 |
| Net income CAGR (3Y) %i | -- | 9.53 | 17.12 | 9.40 | -6.64 | -35.58 | 9.07 | -- |
| FCF CAGR (3Y) %i | -7.68 | 16.65 | 11.03 | -2.64 | -24.53 | 19.17 | 22.25 | 15.62 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 13.27 | 9.65 | -1.16 | -0.51 | -25.06 | -24.89 |
| ROA %i | 5.51 | 4.01 | -0.48 | -0.22 | -10.03 | -9.81 |
| ROIC %i | 9.21 | 6.68 | 1.18 | 1.16 | -11.01 | -10.70 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.57 | 13.33 | 4.59 | 4.91 | -12.71 | -13.28 |
| FCF / sales %i | 11.22 | 9.96 | 7.80 | 7.53 | 8.68 | 7.80 |
| Current ratioi | 0.71 | 1.06 | 0.89 | 0.90 | 0.90 | 1.10 |
| Quick ratioi | 0.19 | 0.40 | 0.24 | 0.25 | 0.27 | 0.34 |
| Debt / assetsi | 38.54 | 39.11 | 39.02 | 38.17 | 42.08 | 43.84 |
| LT debt / equityi | 69.79 | 81.01 | 79.83 | 79.09 | 101.55 | 108.36 |
| Interest coveragei | 3.76 | 3.73 | 1.29 | 1.40 | -3.68 | -3.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Refrigerated & Frozen is the largest reported line at 40.59% of revenue, across 4 reported segments.
- No single line clears half of revenue; Grocery & Snacks is next at 40.49%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Refrigerated & Frozen40.59%
Grocery & Snacks40.49%
Foodservice10.51%
International8.40%
Quote time 2026-10-08 08:15:31 · For reference only, not investment advice and not tailored to your situation.